Efficacy shown for new melanoma therapeutic vaccine

by

In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *